Presymptomatic Parkinson's disease: The Arizona experience

Parkinsonism and Related Disorders

Volumn 18, Issue SUPPL. 1, 2012, Pages

  Caviness, John N ^a  

^a MAYO CLINIC   (United States)

Author keywords

Brain bank; EEG; EMG; Lewy body; Parkinson's disease; Presymptomatic

Indexed keywords

ARTICLE; ASYMPTOMATIC DISEASE; BRADYKINESIA; CLINICAL ASSESSMENT; DIFFUSE LEWY BODY DISEASE; ELECTROENCEPHALOGRAPHY; NERVOUS SYSTEM ELECTROPHYSIOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; REST; RISK ASSESSMENT; SCREENING TEST; TREMOR; UNITED STATES; ALZHEIMER DISEASE; ARIZONA; AUTOPSY; COGNITION; CONSENSUS; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGICAL PROCEDURES; HUMAN; MOTOR DYSFUNCTION; NEUROPATHOLOGY; RISK FACTOR;

BIOLOGICAL MARKER;

EID: 84858630931     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/s1353-8020(11)70063-3     Document Type: Article

References (24)

1. Tredici K, Braak H. A timeline for Parkinson's disease. Parkinsonism Relat Disord 2010;16(2):79-84.
2. Postuma RB, Montplaisir J. Predicting Parkinson's diease - why, when, and how? Parkisonism Relat Disord 2009;15(Suppl. 4):S105-9.
3. Schapira AH. Neuroprotection in Parkinson's disease. Parkinsonism Relat Disord 2009;15:Suppl. 4:S41-S43.
4. Pavese N, Kiferle L, Piccini P. Parkinsonism Relat Disord 2009;15(Suppl 4): S33-7.
5. Beach TG, Sue LI, Walker DG, Roher AH, Lue L, Vedders L, et al. The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007. Cell Tissue Bank 2008;9(3):229-45.
6. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-98.
7. Reisberg B, Ferris SH, de Leon MJ, Crook T. Global Deterioration Scale (GDS). Psychopharmacol Bull 1988;24:661-3.
8. Reisberg B. Functional assessment staging (FAST). Psychopharmacol Bull 1988; 24:653-9.
9. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-4.
10. Adler CH, Hentz JG, Shill HA, Sabbagh MN, Driver-Dunckley ED, Evidente VGH, et al. Probable RBD is increased in Parkinson's disease but not in essential tremor or restless legs syndrome. Parkinsonism Relat Disord 2011;17:456-8.
11. Adler CH, Hentz JG, Joyce JN, Beach TG, Caviness JN. Motor Impairment in Normal Aging, clinically possible Parkinson's disease, and clinically probable Parkinson's disease: Longitudinal evaluation of a cohort of prospective brain donors. Parkinsonism Relat Disord 2002;9:103-10.
12. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. JNNP 1988;51(6):745-52.
13. Adler CH, Connor DJ, Hentz JG, Sabbagh MW, Caviness JN, Shill HA, et al. Incidental Lewy Body Disease: Clinical comparison to a control cohort. Mov Disord 2010;25(5):642-646.
14. Beach TG, Adler CH, Sue LI, Peirce JB, Bachalakuri J, Lue LF, et al. Reduced striatal tyrosine hydroxylase in incidental Lewy body disease. Acta Neuropathol 2008; 115:445-51.
15. Dickson DW, Fujishiro H, DelleDonne A, Menke J, Ahmed Z, Klos KJ, et al. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease. Acta Neuropathol 2008;115:437-44.
16. DelleDonne A, Klos KJ, Fjishiro H, Ahmed Z, Parisi J, Josephs K, et al. Incidental Lewy Body Disease and preclinical Parkinson disease. Arch Neurol 2008;65(8): 1074-80.
17. Frigerio R, Fujishiro H, Maraganore DM, Klos K, DelleDonne A, Heckman MG, et al. Comparison of risk factor profiles in incidental Lewy Body disease and Parkinson's disease. Arch Neurol 2009;66(9):114-9.
18. Fujishiro H, Frigerio R, Burnett M, Klos K, Josephs K, Delledonne A, et al. Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease. Mov Disord 2008;23(8):1085-92.
19. Markesbery WR, Jicha GA, Liu H, Schmitt FA. Lewy Body pathology in normal elderly Subjects. J Neuropathol Exp Neurol 2009;68(7):816-22.
20. Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, et al. Frequency of bowl movements and the future risk of Parkinson's disease. Neurology 2001;57:456-62.
21. Ross GW, Abbott RD, Petrovitch H, Tanner CM, Davis DG, Nelson J, et al. Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord 2006;21:2062-7.
22. Caviness JN, Hentz JG, Evidente VGH, Driver-Dunckley E, Samanta J, Mahant P, et al. Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease. Parkinsonism Relat Disord 2007a;13:348-54.
23. Braak H, Del Tredici K, Rub U, de Vos RA, Stear JEN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24: 197-211.
24. Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, et al. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 2009;117(6):613-34.